The bill H. 4262 introduced in the South Carolina General Assembly seeks to amend the state's laws by adding Section 44-1-175, which prohibits healthcare professionals from administering synthetic mRNA-based gene therapies within South Carolina. The bill outlines specific definitions for synthetic mRNA-based gene therapies and establishes exceptions for certain treatments, such as those for noninfectious diseases, traditional vaccines, and FDA-authorized genetic therapies that do not utilize synthetic mRNA technology.

Additionally, the bill imposes penalties for violations, including a mandatory suspension of the healthcare professional's license for at least one year, with the possibility of further penalties at the discretion of the licensing board. It also mandates that any violations be reported to the Director of the Department of Public Health, who is required to maintain records of these violations for a minimum of seven years and provide annual reports to the General Assembly. The act will take effect upon the Governor's approval.

Statutes affected:
03/27/2025: 44-1-175
Latest Version: 44-1-175